Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Open accessThe DOI matches its Crossref record; 162 of the 162 references it cites were found in a registry or an index.
Abstract
Hypoxia and free radicals, such as reactive oxygen and nitrogen species, can alter the function and/or activity of the transcription factor hypoxia-inducible factor 1 (HIF1). Interplay between free radicals, hypoxia and HIF1 activity is complex and can influence the earliest stages of tumour development. The hypoxic environment of tumours is heterogeneous, both spatially and temporally, and can change in response to cytotoxic therapy. Free radicals created by hypoxia, hypoxia-reoxygenation cycling and immune cell infiltration after cytotoxic therapy strongly influence HIF1 activity. HIF1 can then promote endothelial and tumour cell survival. As discussed here, a constant theme emerges: inhibition of HIF1 activity will have therapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many human cancers contain regions of hypoxia because of rapid cell proliferation and the presence of intratumoral blood vessels that are structurally and functionally abnormal, resulting in both spatial and temporal heterogeneity of blood flow (1, 2).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ROS production later stabilizes the HIF-1α protein and increases expression of HIF-1α and its target genes (Moeller et al., 2004;Dewhirst et al., 2008;Harada et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Dewhirst et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedPlum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 1×
“The HIF1α subunit is exquisitely regulated by hydroxylation of proline residues in its oxygen-dependent degradation domain (ODD) that target it for recognition by the von Hippel Lindau (VHL) complex and subsequent proteasomal degradation under aerobic condition”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“Origins of hypoxia in solid tumours The presence of hypoxia in tumours is a well-established source of resistance to radiation therapy and chemotherap”
BackgroundTransplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000 · cited 1×
“, but it is regulated by many factors aside from hypoxia, including oncogenes, growth factors and free radical”
BackgroundOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468 · cited 1×
“HIF1 consists of α and β subunits, which heterodimerize and bind to DNA at hypoxia response elements (HREs) in promoter or enhancer regions of numerous genes to upregulate their transcriptio”
BackgroundKedersha, N. L., Gupta, M., Li, W., Miller, I., & Anderson, P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.7.1431 · Cited by 1,256
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
Self-citationDistribution of hematopoietic stem cells in the bone marrow according to regional hypoxia
Parmar, K., Mauch, P., Vergilio, J.-A., Sackstein, R., & Down, J. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701152104 · Cited by 867
The discovery of nitric oxide and its role in vascular biology
Moncada, S., & Higgs, E. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706458 · Cited by 863 · cited 1×
“There are three isoforms of nitric oxide synthase that produce NO from L -arginin”
BackgroundTumor hypoxia: causative factors, compensatory mechanisms, and cellular response
Vaupel, P., & Harrison, L. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-4 · Cited by 761
Holash, J., Wiegand, S. J., & Yancopoulos, G. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203035 · Cited by 744
Detection and Characterization of Tumor Hypoxia Using pO 2 Histography
Vaupel, P., Höckel, M., & Mayer, A. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1628 · Cited by 728
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719
Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
Hagen, T., Taylor, C. T., Lam, F., & Moncada, S. (2003) · Science · doi:10.1126/science.1088805 · Cited by 704 · cited 1×
“Using reporter genes that were targeted to either mitochondria or cytosol, Hagen demonstrated that NO inhibits respiration by inhibiting cytochrome c oxidase activity under hypoxic conditions, thereby permitting increased PHD activity as oxygen is redistributed to the cytoso”
BackgroundSenger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620
Mansfield, K. D., Guzy, R. D., Pan, Y., Young, R. M., Cash, T. P., Schumacker, P. T., & Simon, M. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.003 · Cited by 606
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
Bos, R., Zhong, H., Hanrahan, C. F., Mommers, E. C. M., Semenza, G. L., Pinedo, H. M., Abeloff, M. D., Simons, J. W., van Diest, P. J., & van der Wall, E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.309 · Cited by 593
Bell, E. L., Klimova, T. A., Eisenbart, J., Moraes, C. T., Murphy, M. P., Budinger, G. R. S., & Chandel, N. S. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200609074 · Cited by 568
Retinal Oxygen: Fundamental and Clinical Aspects
Wangsa-Wirawan, N. D. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.4.547 · Cited by 546
Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation
Brown, J. M. (1979) · The British Journal of Radiology · doi:10.1259/0007-1285-52-620-650 · Cited by 526
Virchow, R. (1978) · Springer eBooks · doi:10.1007/978-3-642-66491-5 · Cited by 482
Intermittent blood flow in a murine tumor: radiobiological effects.
Chaplin, D. J., Olive, P. L., & Durand, R. E. (1987) · PubMed · Cited by 480
Free radical biology and medicine: it's a gas, man!
Pryor, W. A., Houk, K. N., Foote, C. S., Fukuto, J. M., Ignarro, L. J., Squadrito, G. L., & Davies, K. J. A. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00614.2005 · Cited by 465
Regulation of HIF-1α Stability through S-Nitrosylation
Li, F., Sonveaux, P., Rabbani, Z. N., Liu, S., Yan, B., Huang, Q., Vujaskovic, Z., Dewhirst, M. W., & Li, C.-Y. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.024 · Cited by 437
Self-citationKimura, H., Braun, R. D., Ong, E. T., Hsu, R., Secomb, T. W., Papahadjopoulos, D., Hong, K., & Dewhirst, M. W. (1996) · PubMed · Cited by 425
Self-citationA model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype
Naumov, G. N., Bender, E., Zurakowski, D., Kang, S.-Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj068 · Cited by 423 · cited 1×
“VEGF upregulation is a trigger for initiation of angiogenesis from dormant metastases and the angiogenesis inhibitor thrombospondin 1 might inhibit VEGF activity to promote dormancy”
BackgroundPleiotropic effects of HIF-1 blockade on tumor radiosensitivity
Moeller, B. J., Dreher, M. R., Rabbani, Z. N., Schroeder, T., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.016 · Cited by 374 · cited 1×
“Antisense knockdown or pharmacological inhibition of HIF1 synthesis after radiation treatment was shown to also induce significant growth delay in several tumour lines by our grou”
BackgroundSelf-citationPeng, Y., Yuan, G., Ramakrishnan, D., Sharma, S. D., Bosch‐Marce, M., Kumar, G. K., Semenza, G. L., & Prabhakar, N. R. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.114033 · Cited by 366
Imaging oxygenation of human tumours
Padhani, A. R., Krohn, K. A., Lewis, J. S., & Alber, M. (2007) · European Radiology · doi:10.1007/s00330-006-0431-y · Cited by 328
Sorg, B. S., Moeller, B. J., Donovan, O., Cao, Y., & Dewhirst, M. W. (2005) · Journal of Biomedical Optics · doi:10.1117/1.2003369 · Cited by 306
Self-citationArteel, G., Thurman, R., Yates, J., & Raleigh, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.429 · Cited by 295
Inhibition of Hypoxia-inducible Factor 1 Activation by Carbon Monoxide and Nitric Oxide
Huang, L. E., Willmore, W. G., Gu, J., Goldberg, M. A., & Bunn, H. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9038 · Cited by 291
Braun, R. D., Lanzen, J. L., Snyder, S. A., & Dewhirst, M. W. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.6.h2533 · Cited by 285 · cited 1×
“The average partial pressure of O 2 (pO 2 ) of normal tissues usually exceeds 20 mmH”
BackgroundSelf-citationAnalysis of the Effects of Oxygen Supply and Demand on Hypoxic Fraction in Tumors
Secomb, T. W., Hsu, R., Ong, E. T., Gross, J. F., & Dewhirst, M. W. (1995) · Acta Oncologica · doi:10.3109/02841869509093981 · Cited by 276
Self-citationPatan, S., Munn, L. L., & Jain, R. K. (1996) · Microvascular Research · doi:10.1006/mvre.1996.0025 · Cited by 266
Acute hypoxia in tumors: Implications for modifiers of radiation effects
Chaplin, D. J., Durand, R. E., & Olive, P. L. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90153-7 · Cited by 263
Kimura, H., Weisz, A., Ogura, T., Hitomi, Y., Kurashima, Y., Hashimoto, K., D'Acquisto, F., Makuuchi, M., & Esumi, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008398200 · Cited by 259
MATEO, J., GARCÍA-LECEA, M., CADENAS, S., HERNÁNDEZ, C., & MONCADA, S. (2003) · Biochemical Journal · doi:10.1042/bj20031155 · Cited by 258
Lin, P., Polverini, P., Dewhirst, M., Shan, S., Rao, P. S., & Peters, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119740 · Cited by 252
Self-citationYuan, G., Nanduri, J., Bhasker, C. R., Semenza, G. L., & Prabhakar, N. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407706200 · Cited by 245
Raleigh, J. A., Calkins-Adams, D. P., Rinker, L. H., Ballenger, C. A., Weissler, M. C., Fowler, W. C., Novotny, D. B., & Varia, M. A. (1998) · PubMed · Cited by 241
Mazure, N. M., Chen, E. Y., Yeh, P., Laderoute, K. R., & Giaccia, A. J. (1996) · PubMed · Cited by 239
Green's Function Methods for Analysis of Oxygen Delivery to Tissue by Microvascular Networks
Secomb, T. W., Hsu, R., Park, E. Y. H., & Dewhirst, M. W. (2004) · Annals of Biomedical Engineering · doi:10.1114/b:abme.0000049036.08817.44 · Cited by 238
Self-citationLiu, Y., Christou, H., Morita, T., Laughner, E., Semenza, G. L., & Kourembanas, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15257 · Cited by 220
Stessels, F., Van den Eynden, G., Van der Auwera, I., Salgado, R., Van den Heuvel, E., Harris, A. L., Jackson, D. G., Colpaert, C. G., Van Marck, E. A., Dirix, L. Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601727 · Cited by 214
Reproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer
Nehmeh, S. A., Lee, N. Y., Schröder, H., Squire, O., Zanzonico, P. B., Erdi, Y. E., Greco, C., Mageras, G., Pham, H. S., Larson, S. M., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.036 · Cited by 210
Koch, C. J. (2002) · Methods in Enzymology · doi:10.1016/s0076-6879(02)52003-6 · Cited by 207
Rosmorduc, O., Wendum, D., Corpechot, C., Galy, B., Sebbagh, N., Raleigh, J., Housset, C., & Poupon, R. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65209-1 · Cited by 205
Analysis of oxygen transport to tumor tissue by microvascular networks
Secomb, T. W., Hsu, R., Dewhirst, M. W., Klitzman, B., & Gross, J. F. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90070-c · Cited by 204
Self-citation(2020) · CRC Press eBooks · doi:10.1201/9780429283024 · Cited by 202
Zhou, S., Kachhap, S., Sun, W., Wu, G., Chuang, A., Poeta, L., Grumbine, L., Mithani, S. K., Chatterjee, A., Koch, W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610818104 · Cited by 198
AKT Signaling in Regulating Angiogenesis
Jiang, B.-H., & Liu, L.-Z. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783497122 · Cited by 193
Martinive, P., Defresne, F., Bouzin, C., Saliez, J., Lair, F., Grégoire, V., Michiels, C., Dessy, C., & Feron, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2056 · Cited by 190 · cited 1×
“This effect may be regulated by increased phosphorylation of HIF1&alpha”
BackgroundDewhirst, M. W., Ong, E. T., Braun, R. D., Smith, B., Klitzman, B., Evans, S. M., & Wilson, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690273 · Cited by 187
Self-citationWinkles, J. A., Friesel, R., Burgess, W. H., Howk, R., Mehlman, T., Weinstein, R., & Maciag, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7124 · Cited by 185
Pagé, E. L., Chan, D. A., Giaccia, A. J., Levine, M., & Richard, D. E. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0612 · Cited by 181 · cited 1×
“It has recently been shown that angiotensin II mediates this effect by increasing the levels of H 2 O 2 , which depletes intracellular stores of ascorbate, an important co-factor involved in PHD activit”
BackgroundGoldmann, E. (1908) · PubMed · Cited by 180
Molecular alterations in columnar cell lesions of the breast
Dabbs, D. J., Carter, G., Fudge, M., Peng, Y., Swalsky, P., & Finkelstein, S. (2006) · Modern Pathology · doi:10.1038/modpathol.3800538 · Cited by 179
Koch, C., Evans, S., & Lord, E. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.426 · Cited by 178
The Pervasive Presence of Fluctuating Oxygenation in Tumors
Cárdenas-Navia, L. I., Mace, D., Richardson, R. A., Wilson, D. F., Shan, S., & Dewhirst, M. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6387 · Cited by 176
Self-citationVenkataraman, S., Jiang, X., Weydert, C. J. D., Zhang, Y., Zhang, H. J., Goswami, P. C., Ritchie, J. M., Oberley, L. W., & Buettner, G. R. (2004) · Oncogene · doi:10.1038/sj.onc.1208145 · Cited by 174
Functional Significance of Tie2 Signaling in the Adult Vasculature
Peters, K. G. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.51 · Cited by 169
Raleigh, J. A., Dewhirst, M. W., & Thrall, D. Ε. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80034-8 · Cited by 163
Self-citationDynamics of Tumor Hypoxia Measured with Bioreductive Hypoxic Cell Markers
Ljungkvist, A. S. E., Bussink, J., Kaanders, J. H. A. M., & van der Kogel, A. J. (2007) · Radiation Research · doi:10.1667/rr0719.1 · Cited by 160
Microvascular studies on the origins of perfusion-limited hypoxia.
Dewhirst, M. W., Kimura, H., Rehmus, W., Braun, R. D., Papahadjopoulos, D., Hong, K., & Secomb, T. W. (1996) · Europe PMC (PubMed Central) · Cited by 157
Self-citationBerchner-Pfannschmidt, U., Yamac, H., Trinidad, B., & Fandrey, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607065200 · Cited by 155
Angioadaptation: Keeping the Vascular System in Shape
Zakrzewicz, A., Secomb, T. W., & Pries, A. R. (2002) · Physiology · doi:10.1152/nips.01395.2001 · Cited by 153
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
Milas, L., Hunter, N. R., Mason, K. A., Milross, C., Saito, Y., & Peters, L. J. (1995) · PubMed · Cited by 148
Ljungkvist, A. S. E., Bussink, J., Rijken, P. F. J. W., Kaanders, J. H. A. M., van der Kogel, A. J., & Denekamp, J. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02938-3 · Cited by 145
Molecular Imaging: Principles and Practice
Kim, E. E. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092270 · Cited by 143
Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1
Williams, K. J., Telfer, B. A., Xenaki, D., Sheridan, M. T., Desbaillets, I., Peters, H., Honess, D. J., Harris, A. L., Dachs, G. U., van der Kogel, A., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.01.009 · Cited by 143
Wang, M., Kirk, J. S., Venkataraman, S., Domann, F. E., Zhang, H. J., Schafer, F. Q., Flanagan, S. W., Weydert, C. J. D., Spitz, D. R., Buettner, G. R., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208986 · Cited by 143
Induction of Hypoxia-Inducible-Factor 1 by Nitric Oxide Is Mediated via the PI 3K Pathway
Sandau, K. B., Faus, H., & Brüne, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3789 · Cited by 140
Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile
Dabbs, D. J., Chivukula, M., Carter, G. J., & Bhargava, R. (2006) · Modern Pathology · doi:10.1038/modpathol.3800678 · Cited by 139
Khan, N. I., Williams, B. B., Hou, H. G., Li, H., & Swartz, H. M. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1635 · Cited by 135
Lanzen, J., Braun, R. D., Klitzman, B., Brizel, D., Secomb, T. W., & Dewhirst, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-03-2958 · Cited by 133
Self-citationJanssen, H. L., Haustermans, K. M., Sprong, D., Blommestijn, G. J. F., Hofland, I., Hoebers, F. J. P., Blijweert, E., Raleigh, J. A., Semenza, G. L., Varia, M. A., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03935-4 · Cited by 133
HIF-1–Dependent Respiratory, Cardiovascular, and Redox Responses to Chronic Intermittent Hypoxia
Semenza, G. L., & Prabhakar, N. R. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1691 · Cited by 130
Laderoute, K. R., Alarcon, R. M., Brody, M. D., Calaoagan, J. M., Chen, E. Y., Knapp, A. M., Yun, Z., Denko, N. C., & Giaccia, A. J. (2000) · PubMed · Cited by 129
Le, Q., Kong, C. S., Lavori, P. W., O'Byrne, K. J., Erler, J. T., Huang, X., Chen, Y., Cao, H., Tibshirani, R. J., Denko, N., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.071 · Cited by 129
Raleigh, J., Dewhirst, M. W., & Thrall, D. (1996) · PubMed · doi:10.1053/srao0060037 · Cited by 128
Self-citationBelAiba, R. S., Djordjevic, T., Bonello, S., Flügel, D., Hess, J., Kietzmann, T., & Görlach, A. (2004) · Biological Chemistry · doi:10.1515/bc.2004.019 · Cited by 126
Requirements for T Lymphocyte Migration in Explanted Lymph Nodes
Huang, J. H., Cárdenas-Navia, L. I., Caldwell, C. C., Plumb, T. J., Radu, C. G., Rocha, P. N., Wilder, T., Bromberg, J. S., Cronstein, B. N., Sitkovsky, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7747 · Cited by 125
Self-citationFeldkamp, M. M., Lau, N. C., Rak, J. W., Kerbel, R. S., & Guha, A. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990331)81:1<118::aid-ijc20>3.0.co;2-5 · Cited by 124
Braun, R. D., Lanzen, J. L., & Dewhirst, M. W. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.2.h551 · Cited by 119
Self-citationEarly Wound Healing Exhibits Cytokine Surge Without Evidence of Hypoxia
Haroon, Z. A., Raleigh, J. A., Greenberg, C. S., & Dewhirst, M. W. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00020 · Cited by 117
Self-citationVascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
Wijffels, K. I. E. M., Kaanders, J. H. A. M., Rijken, P. F. J. W., Bussink, J., van den Hoogen, F. J. A., Marres, H. A. M., de Wilde, P. C. M., Raleigh, J. A., & van der Kogel, A. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1325 · Cited by 110
HIF‐1α protein as a target for S‐nitrosation
Sumbayev, V. V., Budde, A., Zhou, J., & Brüne, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03887-5 · Cited by 108
Intermittent Hypoxia Furthers the Rationale for Hypoxia-Inducible Factor-1 Targeting
Dewhirst, M. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4744 · Cited by 108
Self-citationBaudelet, C., Ansiaux, R., Jordan, B. F., Havaux, X., Macq, B., & Gallez, B. (2004) · Physics in Medicine and Biology · doi:10.1088/0031-9155/49/15/006 · Cited by 108
Quintero, M., Brennan, P. A., Thomas, G. J., & Moncada, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0333 · Cited by 106
Microcirculation of tumors part II: The supervascularized state of irradiated regressing tumors
Rubin, P., & Casarett, G. W. (1966) · Clinical Radiology · doi:10.1016/s0009-9260(66)80052-1 · Cited by 104
The Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer
Moon, E. J., Brizel, D. M., Chi, J., & Dewhirst, M. W. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1623 · Cited by 103
Self-citationFluctuations in microvascular blood flow parameters caused by hemodynamic mechanisms
Kiani, M. F., Pries, A. R., Hsu, L. L., Sarelius, I. H., & Cokelet, G. R. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.5.h1822 · Cited by 102
Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry
Pigott, K., Hill, S. A., Chaplin, D. J., & Saunders, M. I. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01730-6 · Cited by 98
Non-Invasive PET and Spect Imaging of Tissue Hypoxia Using Isotopically Labeled 2-Nitroimidazoles
Koch, C. J., & Evans, S. M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0205-0_47 · Cited by 96
Bussink, J., Kaanders, J. H. A. M., Rijken, P. F. J. W., Raleigh, J. A., & Van der Kogel, A. J. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0398:cibpah]2.0.co;2 · Cited by 94
Tumor-dependent Kinetics of Partial Pressure of Oxygen Fluctuations during Air and Oxygen Breathing
Cárdenas-Navia, L. I., Yu, D., Braun, R. D., Brizel, D. M., Secomb, T. W., & Dewhirst, M. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0947 · Cited by 93
Self-citationCao, Y., Li, C.-Y., Moeller, B. J., Yu, D., Zhao, Y., Dreher, M. R., Shan, S., & Dewhirst, M. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4553 · Cited by 92 · cited 1×
“Sometimes, the vascular network changed so dramatically that the same microvessels could not be observed seriall”
BackgroundSelf-citationJankovic, B., Aquino‐Parsons, C., Raleigh, J. A., Stanbridge, E. J., Durand, R. E., Banath, J. P., MacPhail, S. H., & Olive, P. L. (2006) · Cytometry Part B: Clinical Cytometry · doi:10.1002/cyto.b.20086 · Cited by 87
Hypoxia in the thymus: role of oxygen tension in thymocyte survival
Hale, L. P., Braun, R. D., Gwinn, W. M., Greer, P. K., & Dewhirst, M. W. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00682.2001 · Cited by 87
Self-citationIntermittent Blood Flow in Solid Tumours – an under-appreciated Source of ‘drug Resistance’
Durand, R. E. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013181107707 · Cited by 82
Chou, S. C., Azuma, Y., Varia, M. A., & Raleigh, J. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601585 · Cited by 82
Steinman, S., Wang, J., Bourne, P. A., Yang, Q., & Tang, P. (2007) · PubMed · Cited by 82
Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer
Zhu, Y., Denhardt, D. T., Cao, H., Sutphin, P. D., Koong, A. C., Giaccia, A. J., & Le, Q. (2005) · Oncogene · doi:10.1038/sj.onc.1208800 · Cited by 79
Toffoli, S., Féron, O., Raes, M. J., & Michiels, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.06.002 · Cited by 78
Tumour Regrowth after Irradiation: An Experimental Approach
Yamaura, H., & Matsuzawa, T. (1979) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553007914550241 · Cited by 76
Sorg, B. S., Hardee, M. E., Agarwal, N., Moeller, B. J., & Dewhirst, M. W. (2008) · Journal of Biomedical Optics · doi:10.1117/1.2837439 · Cited by 75
Self-citationA manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness
Moeller, B. J., Batinic̈‐Haberle, I., Spasojević, I., Rabbani, Z. N., Anscher, M. S., Vujašković, Ž., & Dewhirst, M. W. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.026 · Cited by 75
Self-citationBaudelet, C., Cron, G. O., Ansiaux, R., Crokart, N., DeWever, J., Feron, O., & Gallez, B. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1002 · Cited by 69
Chemo-radiotherapy: radiosensitizing nucleoside analogues (review).
Grégoire, V., Hittelman, W. N., Rosier, J.-F., & Milas, L. (1999) · Oncology Reports · doi:10.3892/or.6.5.949 · Cited by 67
Vordermark, D., & Brown, J. M. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00289-x · Cited by 67
Laughlin, K. M., Evans, S. M., Jenkins, W. T., Tracy, M., Chan, C. Y., Lord, E. M., & Koch, C. J. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12892-9 · Cited by 67
Heterogeneity in tumor microvascular response to radiation
Dewhirst, M. W., Oliver, R., Tso, C. Y., Gustafson, C., Secomb, T. W., & Gross, J. F. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90061-n · Cited by 65
Self-citationMagnon, C., Opolon, P., Ricard, M., Connault, E., Ardouin, P., Galaup, A., Métivier, D., Bidart, J.-M., Germain, S., Perricaudet, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30269 · Cited by 65
Improved Immunohistochemical Method for Detecting Hypoxia Gradients in Mouse Tissues and Tumors
Samoszuk, M. K., Walter, J., & Mechetner, E. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4b6248.2004 · Cited by 65
Brurberg, K. G., Skogmo, H. K., Graff, B. A., Olsen, D. R., & Rofstad, E. K. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.09.009 · Cited by 62
Spatially Resolved Biologic Information from In Vivo EPRI, OMRI, and MRI
Matsumoto, K., Subramanian, S., Murugesan, R., Mitchell, J. B., & Krishna, M. C. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1638 · Cited by 61
Fluctuations in tumor blood perfusion assessed by dynamic contrast‐enhanced MRI
Brurberg, K. G., Benjaminsen, I. C., Dørum, L. M., & Rofstad, E. K. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21367 · Cited by 60
Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy
Dewhirst, M. W., Cao, Y., Li, C. Y., & Moeller, B. J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.016 · Cited by 60
Self-citationOrally administered pimonidazole to label hypoxic tumor cells.
Bennewith, K. L., Raleigh, J. A., & Durand, R. E. (2002) · PubMed · Cited by 59
Sioussat, T. M., Dvorak, H. F., Brock, T. A., & Senger, D. R. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1109 · Cited by 58
Tumor Reoxygenation as a Mechanism of Taxol-Induced Enhancement of Tumor Radioresponse
Milas, L., Hunter, N. R., Mason, K. A., Milross, C., & Peters, L. J. (1995) · Acta Oncologica · doi:10.3109/02841869509093999 · Cited by 56
Kamat, C. D., Green, D. E., Warnke, L. A., Thorpe, J. E., Ceriello, A., & Ihnat, M. A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.08.017 · Cited by 56
Clinical Relevance of Intermittent Tumour Blood Flow
Aquino-Parsons, R. E. D. (2001) · Acta Oncologica · doi:10.1080/02841860152708206 · Cited by 55
Kavanagh, B. D., Coffey, B. E., Needham, D., Hochmuth, R. M., & Dewhirst, M. W. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.134 · Cited by 54
Self-citationIntermittent blood flow in the KHT sarcoma--flow cytometry studies using Hoechst 33342
Minchinton, A. I., Durand, R. E., & Chaplin, D. J. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.259 · Cited by 54
Fannon, M. W., Forsten‐Williams, K., Dowd, C. J., Freedman, D. A., Folkman, J., & Nugent, M. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0935fje · Cited by 51
Targeting hypoxia and angiogenesis through HIF-1alpha inhibition
Diaz-Gonzalez, J. A., Russell, J., Rouzaut, A., Gil-Bazo, I., & Montuenga, L. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.10.2195 · Cited by 50
Oxygenation and reoxygenation in 'sandwich' tumours.
Hs, R., Blachiwiecz, B., & Blok, A. P. R. (1977) · PubMed · Cited by 46
Colpaert, C., Vermeulen, P., van Beest, P., Soubry, A., Goovaerts, G., Dirix, L. Y., Harris, A. L., & Marck, E. A. V. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01629.x · Cited by 45
Effect of longitudinal oxygen gradients on effectiveness of manipulation of tumor oxygenation.
Erickson, K., Braun, R. D., Yu, D., Lanzen, J. L., Wilson, D. F., Brizel, D. M., Secomb, T. W., Biaglow, J. E., & Dewhirst, M. W. (2003) · PubMed · Cited by 43
Self-citationDiameter variability and microvascular flow resistance
Pries, A. R., Schönfeld, D., Gaehtgens, P. A. L., Kiani, M. F., & Cokelet, G. R. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.6.h2716 · Cited by 43
Devasahayam, N., Subramanian, S., Murugesan, R., Hyodo, F., Matsumoto, K., Mitchell, J. B., & Krishna, M. C. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21194 · Cited by 42
Oxygenation of human tumors: the Mainz experience.
Vaupel, P. W., Thews, O., Kelleher, D. K., & Hoeckel, M. (1998) · PubMed · Cited by 41
Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects
Tozer, G. M., & Everett, S. A. (1997) · Clinical Oncology · doi:10.1016/s0936-6555(05)80061-5 · Cited by 40
Is hypoxia involved in the mechanism of alcohol-induced liver injury?*1
Thurman, R. G. (1984) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(84)90112-x · Cited by 36
Srinivasan, S., Pogue, B. W., Carpenter, C. M., Jiang, S., Wells, W. A., Poplack, S. P., Kaufman, P. A., & Paulsen, K. D. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1643 · Cited by 35
Trotter, M. J., Chaplin, D. J., & Olive, P. L. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90140-9 · Cited by 32
Coronary intercapillary distance during growth: relation to PtO2 and aerobic capacity
Henquell, L., Cl, O., & Honig, C. R. (1976) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1976.231.6.1852 · Cited by 31
Non-constant Tumour Blood Flow&Implications for Therapy
Aquino‐Parsons, C. (2001) · Acta Oncologica · doi:10.1080/02841860152703508 · Cited by 27
Evidence for intermittent radiobiological hypoxia in experimental tumour systems.
Chaplin, D. J., Trotter, M. J., Durand, R. E., Olive, P. L., & Minchinton, A. I. (1989) · PubMed · Cited by 23
Nitric oxide in tumour biology and cancer therapy. Part 2: Therapeutic implications
Tozer, G. M., & Everett, S. A. (1997) · Clinical Oncology · doi:10.1016/s0936-6555(97)80128-8 · Cited by 22
Thomas, C. D., Stern, S., Chaplin, D. J., & Guichard, M. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01734-3 · Cited by 18
Cytotoxic treatments and tumor oxygenation.
Milas, L., Milross, C., & Mason, K. A. (2006) · PubMed · Cited by 1
(2002) · PubMed
Cited by
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Metadata
- Authors
- Dewhirst, M. W., Cao, Y., & Moeller, B.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Dewhirst, Mark W.
- Venue
- Nature Reviews Cancer
- Published
- 2008-06
- Volume
- 8
- Issue
- 6
- Pages
- 425-437
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3943205
- OpenAlex
- W2016861891
- Cited by
- 1,022
- References
- 161
- Citations by year
- 2026: 27 · 2025: 29 · 2024: 30 · 2023: 52 · 2022: 60 · 2021: 70 · 2020: 76 · 2019: 44 · 2018: 64 · 2017: 53 · 2016: 73 · 2015: 65 · 2014: 63 · 2013: 63 · 2012: 62
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-07-03)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA40355, R01CA040355, P50CA068438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Kruppel-like factors research
- Keywords
- tumor hypoxia, free radicals, reactive oxygen species, reactive nitrogen species, HIF-1, tumor angiogenesis, radiotherapy response, tumor heterogeneity, immune cell infiltration, tumor cell survival, endothelial cells
- MeSH terms
- Animals, Free Radicals, Humans, Neoplasms, Neovascularization, Pathologic, Nitric Oxide, Oxygen, Cell Hypoxia, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.